bluebird bio IncNASDAQ:BLUENASDAQ FSI:E. Delinquent (Issuer missed regulatory filing deadline)
- LAST PRICE1.0100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0100/ 2
- Ask / Lots1.0200/ 2
- Open / Previous Close0.0000 / 1.0100
- Day Range---
- 52 Week Range
- Volume276
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLUE |
|---|---|---|
| 09:32 ET | 149229 | 1.0397 |
| 09:34 ET | 65279 | 1 |
| 09:36 ET | 9185 | 1.0099 |
| 09:38 ET | 37459 | 1 |
| 09:39 ET | 76538 | 1 |
| 09:41 ET | 25937 | 1.0009 |
| 09:43 ET | 10395 | 1.005 |
| 09:45 ET | 6543 | 1.005 |
| 09:48 ET | 26590 | 0.9959 |
| 09:50 ET | 34934 | 0.9991 |
| 09:52 ET | 45114 | 0.9896 |
| 09:54 ET | 38082 | 0.982 |
| 09:56 ET | 23460 | 0.9958 |
| 09:57 ET | 12564 | 0.9853 |
| 09:59 ET | 13400 | 0.9883 |
| 10:01 ET | 24099 | 0.9997 |
| 10:03 ET | 17876 | 0.9916 |
| 10:06 ET | 83400 | 0.9914 |
| 10:08 ET | 64530 | 0.9982 |
| 10:10 ET | 96394 | 0.985 |
| 10:12 ET | 12289 | 0.985 |
| 10:14 ET | 24227 | 0.985 |
| 10:15 ET | 37323 | 0.9955 |
| 10:17 ET | 34333 | 1.0099 |
| 10:19 ET | 24624 | 1.0011 |
| 10:21 ET | 19494 | 1.005 |
| 10:24 ET | 14410 | 1.005 |
| 10:26 ET | 9700 | 1.01 |
| 10:28 ET | 12123 | 1.01 |
| 10:30 ET | 2165 | 1.0025 |
| 10:32 ET | 16861 | 1.006 |
| 10:33 ET | 90819 | 1 |
| 10:35 ET | 2500 | 1.005 |
| 10:37 ET | 3561 | 1.0003 |
| 10:39 ET | 8327 | 1.005 |
| 10:42 ET | 38226 | 1.005 |
| 10:44 ET | 17559 | 1 |
| 10:46 ET | 1091 | 1.005 |
| 10:48 ET | 1982 | 1.0025 |
| 10:50 ET | 3500 | 1.01 |
| 10:51 ET | 12711 | 1.02 |
| 10:53 ET | 39570 | 1.03 |
| 10:55 ET | 11278 | 1.03 |
| 10:57 ET | 10218 | 1.0299 |
| 11:00 ET | 21914 | 1.025 |
| 11:02 ET | 4463 | 1.025 |
| 11:04 ET | 33219 | 1.035 |
| 11:06 ET | 10796 | 1.04 |
| 11:08 ET | 3615 | 1.03 |
| 11:09 ET | 11447 | 1.04 |
| 11:11 ET | 24421 | 1.0396 |
| 11:13 ET | 78178 | 1.0301 |
| 11:15 ET | 34680 | 1.0299 |
| 11:18 ET | 42900 | 1.0386 |
| 11:20 ET | 4875 | 1.03 |
| 11:22 ET | 15186 | 1.04 |
| 11:24 ET | 7414 | 1.03 |
| 11:26 ET | 27228 | 1.03 |
| 11:27 ET | 4859 | 1.031 |
| 11:29 ET | 23590 | 1.02 |
| 11:31 ET | 4201 | 1.025 |
| 11:33 ET | 1529 | 1.02 |
| 11:36 ET | 1825 | 1.0208 |
| 11:38 ET | 5797 | 1.025 |
| 11:40 ET | 22321 | 1.025 |
| 11:42 ET | 32147 | 1.02 |
| 11:44 ET | 26859 | 1.02 |
| 11:45 ET | 16290 | 1.015 |
| 11:47 ET | 5339 | 1.015 |
| 11:49 ET | 5747 | 1.01 |
| 11:51 ET | 1659 | 1.01 |
| 11:54 ET | 5433 | 1.01 |
| 11:56 ET | 3074 | 1.01 |
| 11:58 ET | 3955 | 1.01 |
| 12:00 ET | 3409 | 1.01 |
| 12:02 ET | 5852 | 1.01 |
| 12:03 ET | 3250 | 1.015 |
| 12:05 ET | 7808 | 1.015 |
| 12:07 ET | 2036 | 1.015 |
| 12:09 ET | 1100 | 1.01 |
| 12:12 ET | 1799 | 1.015 |
| 12:14 ET | 3158 | 1.01 |
| 12:16 ET | 6434 | 1.01 |
| 12:18 ET | 537 | 1.0125 |
| 12:20 ET | 2483 | 1.01 |
| 12:21 ET | 24348 | 1.005 |
| 12:23 ET | 1900 | 1.005 |
| 12:25 ET | 1450 | 1.0012 |
| 12:27 ET | 10728 | 1.0095 |
| 12:30 ET | 11255 | 1.0098 |
| 12:32 ET | 16362 | 1.005 |
| 12:34 ET | 10016 | 1.005 |
| 12:36 ET | 4621 | 1.005 |
| 12:38 ET | 1669 | 1 |
| 12:39 ET | 1901 | 1.0092 |
| 12:41 ET | 1020 | 1.005 |
| 12:43 ET | 7716 | 1.0085 |
| 12:45 ET | 681 | 1.005 |
| 12:48 ET | 500 | 1.01 |
| 12:50 ET | 3079 | 1.005 |
| 12:52 ET | 2415 | 1.005 |
| 12:54 ET | 19487 | 1.005 |
| 12:56 ET | 400 | 1.005 |
| 12:57 ET | 711 | 1.005 |
| 12:59 ET | 1637 | 1.01 |
| 01:01 ET | 1125 | 1.01 |
| 01:03 ET | 1636 | 1.0025 |
| 01:06 ET | 6225 | 1.01 |
| 01:08 ET | 3200 | 1.005 |
| 01:10 ET | 800 | 1.01 |
| 01:12 ET | 1400 | 1.005 |
| 01:14 ET | 147140 | 1.0025 |
| 01:15 ET | 18844 | 1.01 |
| 01:17 ET | 33237 | 1.01 |
| 01:19 ET | 1000 | 1.005 |
| 01:21 ET | 8337 | 1.005 |
| 01:24 ET | 1800 | 1.01 |
| 01:26 ET | 4301 | 1.005 |
| 01:28 ET | 9410 | 1.01 |
| 01:30 ET | 100 | 1.0025 |
| 01:32 ET | 8228 | 1.01 |
| 01:33 ET | 100 | 1.015 |
| 01:35 ET | 8878 | 1.0181 |
| 01:37 ET | 4807 | 1.0199 |
| 01:42 ET | 10300 | 1.02 |
| 01:44 ET | 300 | 1.0125 |
| 01:46 ET | 4999 | 1.0125 |
| 01:48 ET | 860 | 1.015 |
| 01:50 ET | 3463 | 1.015 |
| 01:51 ET | 100 | 1.01 |
| 01:53 ET | 2400 | 1.01 |
| 01:55 ET | 12900 | 1.015 |
| 01:57 ET | 2400 | 1.015 |
| 02:00 ET | 20114 | 1.01 |
| 02:02 ET | 2500 | 1.015 |
| 02:04 ET | 5900 | 1.01 |
| 02:06 ET | 2400 | 1.015 |
| 02:08 ET | 646 | 1.015 |
| 02:09 ET | 3200 | 1.0125 |
| 02:11 ET | 600 | 1.015 |
| 02:13 ET | 6730 | 1.01 |
| 02:15 ET | 14454 | 1.011 |
| 02:18 ET | 500 | 1.02 |
| 02:20 ET | 16152 | 1.015 |
| 02:22 ET | 4100 | 1.02 |
| 02:24 ET | 3708 | 1.02 |
| 02:26 ET | 6300 | 1.015 |
| 02:27 ET | 2500 | 1.02 |
| 02:29 ET | 1200 | 1.015 |
| 02:31 ET | 118888 | 0.9989 |
| 02:33 ET | 15823 | 0.9966 |
| 02:36 ET | 31159 | 0.9967 |
| 02:38 ET | 18622 | 0.9968 |
| 02:40 ET | 8100 | 0.9967 |
| 02:42 ET | 200 | 0.9968 |
| 02:44 ET | 59002 | 0.9986 |
| 02:45 ET | 1049 | 1.005 |
| 02:47 ET | 100 | 1 |
| 02:49 ET | 100 | 1 |
| 02:51 ET | 4100 | 1.01 |
| 02:54 ET | 2700 | 1.0007 |
| 02:56 ET | 800 | 1 |
| 02:58 ET | 1395 | 1 |
| 03:00 ET | 12656 | 1 |
| 03:02 ET | 300 | 1.005 |
| 03:03 ET | 2300 | 1.01 |
| 03:05 ET | 12068 | 1.005 |
| 03:07 ET | 700 | 1 |
| 03:09 ET | 932 | 1 |
| 03:12 ET | 679 | 1.0099 |
| 03:14 ET | 2700 | 1.005 |
| 03:16 ET | 1400 | 1.005 |
| 03:18 ET | 2400 | 1 |
| 03:20 ET | 200 | 1 |
| 03:21 ET | 2500 | 1 |
| 03:23 ET | 300 | 1.01 |
| 03:25 ET | 1848 | 1.0001 |
| 03:27 ET | 1700 | 1.005 |
| 03:30 ET | 30460 | 1.02 |
| 03:32 ET | 54399 | 1.0199 |
| 03:34 ET | 1847 | 1.01 |
| 03:36 ET | 41925 | 1.01 |
| 03:38 ET | 2500 | 1.015 |
| 03:39 ET | 4000 | 1.01 |
| 03:41 ET | 15310 | 1.015 |
| 03:43 ET | 2700 | 1.01 |
| 03:45 ET | 3996 | 1.015 |
| 03:48 ET | 13786 | 1.01 |
| 03:50 ET | 11410 | 1.02 |
| 03:52 ET | 6718 | 1.01 |
| 03:54 ET | 69005 | 1.02 |
| 03:56 ET | 91852 | 1.015 |
| 03:57 ET | 38206 | 1.02 |
| 03:59 ET | 58321 | 1.01 |
Yesterday
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUE, from 10 hours ago by Dow Jones
10 hours ago by Dow JonesROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE, from 11 hours ago by Dow Jones
11 hours ago by Dow JonesBLUE LAWSUIT ALERT: Levi & Korsinsky Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline, from 11 hours ago by Dow Jones
11 hours ago by Dow JonesLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE, from 11 hours ago by Dow Jones
11 hours ago by Dow JonesSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm, from 13 hours ago by Dow Jones
13 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
bluebird bio Inc | 192.3M | -1.4x | --- |
Abeona Therapeutics Inc | 177.0M | -1.8x | --- |
Adverum Biotechnologies Inc | 214.6M | -0.9x | --- |
Outlook Therapeutics Inc | 191.3M | -2.1x | --- |
Elevation Oncology Inc | 190.1M | -3.4x | --- |
Trevi Therapeutics Inc | 200.0M | -12.7x | --- |
Company Information
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).
Contact Information
- Headquarters
- 455 Grand Union BoulevardSOMERVILLE, MA, United States 02145
- Phone
- 339-499-9300
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Mark Vachon
- President, Chief Executive Officer, Director
- Andrew Obenshain
- Chief Financial Officer
- Christopher Krawtschuk
- Chief Commercial and Operating Officer
- Thomas Klima
- Chief Medical Officer
- Richard Colvin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $192.3M |
|---|---|
Revenue (TTM) | $21.7M |
Shares Outstanding | 190.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.84 |
EPS | $-0.74 |
Book Value | $2.37 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 8.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -626.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
